Andreas Strüngmann

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Andreas Strüngmann (born 1950) is a German businessman and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer.[1] In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion,[2] making Sandoz the largest generic-drug company in the world.

He currently has residences in Tegernsee and South Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.

See also[edit]

References[edit]

  1. ^ Timmons, Heather & Wright, Tom. "Novartis to Buy Two Makers of Generics". The New York Times, 22 February 2005. Retrieved on 27 May 2013.
  2. ^ Forbes. "Andreas Strungmann - Forbes". March 2013. Retrieved on 27 May 2013.

External links[edit]